An infographic reference card with everything you need to know about the LI-RADS criteria. You’re going to want to bookmark or save this one to your phone!
In Episode 4 of “Conversations with an Expert,” Hersh continues to learn about AUD/ALD in an interview with UMich clinical psychologist Dr. Anne Fernandez.
In Episode 3 of the newly-named “Conversations with an Expert,” Hersh chats with Dr. Gerald Scott Winder to learn the psychiatrist’s perspective on alcohol-related liver disease. Enjoy!
In part 2 of our coagulopathy series, we take a deeper dive and learn the ways in which end-stage liver disease alters the body’s normal hemostatic mechanisms.
Patients with end-stage liver disease have elevated INRs. They bleed frequently and they clot perhaps more frequently. Do they need FFP before a paracentesis? What’s a TEG? These questions answered, and more, in our multi-part series on the coagulopathy of liver disease!
In episode 2, Hersh has the pleasure of sitting down (virtually) with Dr. Jessica Mellinger of the University of Michigan. Join them as they discuss alcohol use disorder in liver transplant recipients.
The first “7 Minutes with an Expert” post, featuring a discussion on the cardiac evaluation of patient’s with liver disease with Northwestern’s Dr. Lisa VanWagner.
Ursodeoxycholic acid (or UDCA, Ursodiol) is a very commonly-used medication in the hepatologist’s arsenal. But have you ever wondered what it is? Why does it work? I know I have.
Let’s try and answer some of those questions for you today!
Where do AST and ALT come from? How is bilirubin metabolized? Get to “know” your liver chemistries with this Quick Tips infographic!
Why, after an episode of prolonged biliary obstruction, or after severe forms of acute liver injury, does the alkaline phosphatase (ALP) rise in a delayed fashion? And why do the ALP and total bilirubin often take a while to normalize? We’ve all heard (or said) this before. Today, let’s get to the bottom of why this happens!